ArticleJournal of interpersonal violence2026
Association of Intimate Partner Violence With Substance Use Among Adults in Same-Sex and Opposite-Sex Partnerships.
Article in Journal of interpersonal violence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intimate partner violence (IPV) is linked to harmful drug use, especially in same-sex romantic partnerships, yet few studies use longitudinal data to evaluate this association over the life course. This study used the National Longitudinal Study of Adolescent to Adult Health (Add Health) to examine how IPV reported in Wave IV (2006-2008) relates to non-medical prescription and illicit drug use (drug use) in Wave V (2016-2018), stratified by same- and opposite-sex partnerships. Risk ratios (RR) adjusted for race/ethnicity, sexual orientation, age at IPV, prior substance use, child maltreatment, socioeconomic status, and social support were calculated. Sensitivity analyses additionally adjusted for gender and IPV type (physical or sexual). Among 7,318 participants, 23.0% reported experiences of IPV, 16.5% reported IPV perpetration, 13.7% reported both IPV experiences and perpetration and 13.4% reported drug use in Wave V. Same-sex partnership participants had higher prevalences of IPV experiences and perpetration (13.5% vs. 11.3%) and drug use (21.6% vs. 13.2%) than opposite-sex partnership participants. Overall, participants who reported IPV experiences only (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.